Resmed Inc. buy UBS Group AG
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€284.77
Performance (%)
-24.35%
End price
02.08.26
€182.55
Summary
This prediction ended on 02.08.26 with a price of €182.55. The price of Resmed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.35%. UBS_Group_AG has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -0.483% | -0.483% | -21.100% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at UBS Group AG from $285.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten